(η(4)-1,5-cyclooctadiene)Ir(μ-Cl)2Ir(P(Pr-i)3)2H(CCC6H5) | 344286-83-5

• 英文名称: (η(4)-1,5-cyclooctadiene)Ir(μ-Cl)2Ir(P(Pr-i)3)2H(CCC6H5)
• CAS: 344286-83-5
• 化学式: C₃₄H₆₀Cl₂Ir₂P₂
• 分子量: 986.144
• InChiKey: YHUCGYWEZPAHTL-BANZGMMUSA-L

反应信息

• 作为产物：
  描述：

  (η(4)-1,5-cyclooctadiene)Ir(μ-Cl)2Ir(P(Pr-i)3)2H2 、 苯乙炔 以 甲苯 为溶剂， 以23%的产率得到(η(4)-1,5-cyclooctadiene)Ir(μ-Cl)2Ir(P(Pr-i)3)2H(CCC6H5)
  参考文献：
  名称：

  二氢铱 (III) 配合物 [IrH2Cl(PiPr3)2] 作为不对称铑-铱和铱-铱双核化合物的分子结构单元

  摘要：

  The title compound [IrH2Cl(PiPr(3))(2)] (3) reacts with the chloro-bridged dimers [RhCl(PiPr(3))(2)](2) (1) and [IrCl(C8H14)(PiPr(3))](2) (5) by cleavage of the Cl-bridges to give the unsymmetrical binuclear complexes 4 and 6 with Rh(mu -Cl)(2)Ir and Ir(mu -Cl)(2)Ir as the central building block. The reactions of 3 with the bis(cyclooctene) and (1,5-cyclooctadiene) compounds [MCl(C8H14)(2)](2) (7, 8) and [MCl(eta (4)-C8H12)](2) (9, 10) (M = Rh, Ir) occur analogously and afford the rhodium(I)-iridium(III) and iridium(I)-iridium(III) complexes 11-14 in 70-80% yield. Treatment of [(eta (4)-C8H12)M(mu -Cl)(2)IrH2(PiPr(3))(2)] (13, 14) With phenylacetylene leads to the formation of the substitution products [(eta (4)-C8H12)M(mu -Cl)(2)IrH(C equivalent to CPh)(PiPr(3))(2)] (15, 16) without changing the central molecular core. Similarly, the compound [(eta (4)-C8H12)Rh(mu -Br)(2)IrH(C equivalent to CPh)(PiPr(3))(2)] (18) has been prepared; it was characterized by X-ray crystallography.

  DOI：

  10.1002/1521-3749(200104)627:4<693::aid-zaac693>3.0.co;2-h